1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
2
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar
|
3
|
Bowles J, Schepers G and Koopman P:
Phylogeny of the SOX family of developmental transcription factors
based on sequence and structural indicators. Dev Biol. 227:239–255.
2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chew LJ and Gallo V: The Yin and Yang of
Sox proteins: Activation and repression in development and disease.
J Neurosci Res. 87:3277–3287. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Shiozawa M, Hiraoka Y, Komatsu N, Ogawa M,
Sakai Y and Aiso S: Cloning and characterization of Xenopus
laevis xSox7 cDNA. Biochim Biophys Acta. 1309:73–76. 1996.
View Article : Google Scholar
|
6
|
Taniguchi K, Hiraoka Y, Ogawa M, Sakai Y,
Kido S and Aiso S: Isolation and characterization of a mouse
SRY-related cDNA, mSox7. Biochim Biophys Acta. 1445:225–231. 1999.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Stovall DB, Wan M, Miller LD, et al: The
regulation of SOX7 and its tumor suppressive role in breast cancer.
Am J Pathol. 183:1645–1653. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Guo L, Zhong D, Lau S, et al: Sox7 is an
independent checkpoint for beta-catenin function in prostate and
colon epithelial cells. Mol Cancer Res. 6:1421–1430. 2008.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Endo Y, Deonauth K, Prahalad P, Hoxter B,
Zhu Y and Byers SW: Role of Sox-9, ER81 and VE-cadherin in retinoic
acid-mediated trans-differentiation of breast cancer cells. PLoS
One. 3:e27142008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gandillet A, Serrano AG, Pearson S, Lie
ALM, Lacaud G and Kouskoff V: Sox7-sustained expression alters the
balance between proliferation and differentiation of hematopoietic
progenitors at the onset of blood specification. Blood.
114:4813–4822. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kamachi Y and Kondoh H: Sox proteins:
regulators of cell fate specification and differentiation.
Development. 140:4129–4144. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Chan DW, Mak CS, Leung TH, Chan KK and
Ngan HY: Down-regulation of Sox7 is associated with aberrant
activation of Wnt/b-catenin signaling in endometrial cancer.
Oncotarget. 3:1546–1556. 2012.PubMed/NCBI
|
13
|
Katoh M: Expression of human SOX7 in
normal tissues and tumors. Int J Mol Med. 9:363–368.
2002.PubMed/NCBI
|
14
|
Hayano T, Garg M, Yin D, et al: SOX7 is
down-regulated in lung cancer. J Exp Clin Cancer Res. 32:172013.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Futaki S, Hayashi Y, Emoto T, Weber CN and
Sekiguchi K: Sox7 plays crucial roles in parietal endoderm
differentiation in F9 embryonal carcinoma cells through regulating
Gata-4 and Gata-6 expression. Mol Cell Biol. 24:10492–10503. 2004.
View Article : Google Scholar
|
16
|
Zhang Y, Huang S, Dong W, et al: SOX7,
down-regulated in colorectal cancer, induces apoptosis and inhibits
proliferation of colorectal cancer cells. Cancer Lett. 277:29–37.
2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhong WD, Qin GQ, Dai QS, et al: SOXs in
human prostate cancer: implication as progression and prognosis
factors. BMC Cancer. 12:2482012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Karim R, Tse G, Putti T, Scolyer R and Lee
S: The significance of the Wnt pathway in the pathology of human
cancers. Pathology. 36:120–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Polakis P: Wnt signaling in cancer. Cold
Spring Harb Perspect Biol. 4:2012. View Article : Google Scholar
|
21
|
Kolligs FT, Bommer G and Goke B:
Wnt/beta-catenin/tcf signaling: a critical pathway in
gastrointestinal tumorigenesis. Digestion. 66:131–144. 2002.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhao P, Li Y and Lu Y: Aberrant expression
of CD133 protein correlates with Ki-67 expression and is a
prognostic marker in gastric adenocarcinoma. BMC Cancer.
10:2182010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Xi HQ and Zhao P: Clinicopathological
significance and prognostic value of EphA3 and CD133 expression in
colorectal carcinoma. J Clin Pathol. 64:498–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Filomena A, Saieva C, Lucchetti V, et al:
Gastric cancer surveillance in a high-risk population in tuscany
(Central Italy): preliminary results. Digestion. 84:70–77. 2011.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Wegner M: From head to toes: the multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Kormish JD, Sinner D and Zorn AM:
Interactions between SOX factors and Wnt/beta-catenin signaling in
development and disease. Dev Dyn. 239:56–68. 2010.PubMed/NCBI
|
27
|
Willert K and Nusse R: Beta-catenin: a key
mediator of Wnt signaling. Curr Opin Genet Dev. 8:95–102. 1998.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Wu WK, Cho CH, Lee CW, et al:
Dysregulation of cellular signaling in gastric cancer. Cancer Lett.
295:144–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chan DW, Chan CY, Yam JW, Ching YP and Ng
IO: Prickle-1 negatively regulates Wnt/beta-catenin pathway by
promoting Dishevelled ubiquitination/degradation in liver cancer.
Gastroenterology. 131:1218–1227. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Qi J and Zhu YQ: Targeting the most
upstream site of Wnt signaling pathway provides a strategic
advantage for therapy in colorectal cancer. Curr Drug Targets.
9:548–557. 2008. View Article : Google Scholar : PubMed/NCBI
|
31
|
Takash W, Canizares J, Bonneaud N, et al:
SOX7 transcription factor: sequence, chromosomal localisation,
expression, transactivation and interference with Wnt signalling.
Nucleic Acids Res. 29:4274–4283. 2001. View Article : Google Scholar
|
32
|
Li B, Ge Z, Song S, et al: Decreased
expression of SOX7 is correlated with poor prognosis in lung
adenocarcinoma patients. Pathol Oncol Res. 18:1039–1045. 2012.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Castillo SD and Sanchez-Cespedes M: The
SOX family of genes in cancer development: biological relevance and
opportunities for therapy. Expert Opin Ther Targets. 16:903–919.
2012. View Article : Google Scholar : PubMed/NCBI
|